In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery
Authors
Keywords
-
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-09
DOI
10.1007/s12253-019-00773-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems
- (2019) Krisztina Kiss et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice
- (2019) Ranđelović et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
- (2018) Sabine Schuster et al. Beilstein Journal of Organic Chemistry
- Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property
- (2018) Andrea Angelo Pierluigi Tripodi et al. Beilstein Journal of Organic Chemistry
- NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth
- (2018) Khaled Seidi et al. ONCOGENE
- Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
- (2018) Sabine Schuster et al. Pharmaceutics
- Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side Chain
- (2017) Ryota Kirikoshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NGR-peptide−drug conjugates with dual targeting properties
- (2017) Kata Nóra Enyedi et al. PLoS One
- Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice
- (2016) Bence Kapuvári et al. INVESTIGATIONAL NEW DRUGS
- Development of Cyclic NGR Peptides with Thioether Linkage: Structure and Dynamics Determining Deamidation and Bioactivity
- (2015) Kata Nóra Enyedi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Animal models of human colorectal cancer: Current status, uses and limitations
- (2015) Vijay K Mittal WORLD JOURNAL OF GASTROENTEROLOGY
- Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming
- (2013) Laila Cancian et al. TRENDS IN CELL BIOLOGY
- Matched rabbit monoclonal antibodies against v-series integrins reveal a novel v 3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors
- (2012) S. L. Goodman et al. Biology Open
- Use of Metadynamics in the Design of isoDGR-Based αvβ3 Antagonists To Fine-Tune the Conformational Ensemble
- (2011) Andrea Spitaleri et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
- (2011) Angelo Corti et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Targeted Drug Delivery and Penetration Into Solid Tumors
- (2011) Angelo Corti et al. MEDICINAL RESEARCH REVIEWS
- In vitro degradation and antitumor activity of oxime bond-linked daunorubicin–GnRH-III bioconjugates and DNA-binding properties of daunorubicin–amino acid metabolites
- (2010) Erika Orbán et al. AMINO ACIDS
- Conformational Control of Integrin-Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch
- (2010) Andreas O. Frank et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching
- (2010) Flavio Curnis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome
- (2010) Ayele H. Negussie et al. JOURNAL OF CONTROLLED RELEASE
- Peptide Targeting of Platinum Anti-Cancer Drugs
- (2009) Margaret W. Ndinguri et al. BIOCONJUGATE CHEMISTRY
- Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
- (2009) R. Bieker et al. BLOOD
- Early Events in Kaposi's Sarcoma-Associated Herpesvirus Infection of Target Cells
- (2009) B. Chandran JOURNAL OF VIROLOGY
- The neovasculature homing motif NGR: more than meets the eye
- (2008) A. Corti et al. BLOOD
- Quantitative Molecular Magnetic Resonance Imaging of Tumor Angiogenesis Using cNGR-Labeled Paramagnetic Quantum Dots
- (2008) M. Oostendorp et al. CANCER RESEARCH
- Structural Basis for the Interaction ofisoDGR with the RGD-binding Site of αvβ3 Integrin
- (2008) Andrea Spitaleri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In vivo optical imaging of CD13/APN-expression in tumor xenografts
- (2008) Angelika von Wallbrunn et al. JOURNAL OF BIOMEDICAL OPTICS
- Monoclonal antibody 14C5 targets integrin v 5
- (2008) I. Burvenich et al. MOLECULAR CANCER THERAPEUTICS
- The moonlighting enzyme CD13: old and new functions to target
- (2008) Paola Mina-Osorio TRENDS IN MOLECULAR MEDICINE
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
- (2007) Sumitra Mukhopadhyay et al. BIOCONJUGATE CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started